Investing.com - Koninklijke DSM (OTC:RDSMY) reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Koninklijke DSM announced earnings per share of €1.31 on revenue of €2.19B. Analysts polled by Investing.com anticipated EPS of €1.12 on revenue of €2.22B.
Koninklijke DSM shares are down 22% from the beginning of the year, still down 0.39% from its 52 week high of €155.30 set on May 6. They are under-performing the STOXX 600 which is up 10.14% from the start of the year.
Koninklijke DSM follows other major Healthcare sector earnings this month
Koninklijke DSM's report follows an earnings beat by Philips on April 26, who reported EPS of €0.28 on revenue of €3.8B, compared to forecasts EPS of €0.2023 on revenue of €4.03B.
Kiadis Pharma had missed expectations on April 7 with first quarter EPS of €-1.57 on revenue of €17.50M, compared to forecast for EPS of €-0.2573 on revenue of €0.00.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar